| editorial | Q871232 |
| scholarly article | Q13442814 |
| P50 | author | Andreas Papapetropoulos | Q40644576 |
| P2093 | author name string | Csaba Szabo | |
| Ioanna Andreadou | |||
| Efstathios K Iliodromitis | |||
| P2860 | cites work | Hydrogen sulfide-linked sulfhydration of NF-κB mediates its antiapoptotic actions | Q24301813 |
| Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome | Q24337593 | ||
| Hydrogen sulfide and nitric oxide are mutually dependent in the regulation of angiogenesis and endothelium-dependent vasorelaxation | Q24597604 | ||
| Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners | Q38218546 | ||
| Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | Q38409371 | ||
| Diallyl trisulfide protects against high glucose-induced cardiac apoptosis by stimulating the production of cystathionine gamma-lyase-derived hydrogen sulfide | Q38865887 | ||
| Hydrogen sulfide mediates the cardioprotective effects of gene therapy with PKG-Iα. | Q41189484 | ||
| The coordination of S-sulfhydration, S-nitrosylation, and phosphorylation of endothelial nitric oxide synthase by hydrogen sulfide | Q42465332 | ||
| Hydrogen sulfide is an endogenous inhibitor of phosphodiesterase activity. | Q42969013 | ||
| Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs | Q43690239 | ||
| H2S generated by heart in rat and its effects on cardiac function | Q44698472 | ||
| Effect of sildenafil on reperfusion function, infarct size, and cyclic nucleotide levels in the isolated rat heart model | Q46481871 | ||
| The possible role of hydrogen sulfide as an endogenous neuromodulator. | Q46606180 | ||
| Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. | Q46735649 | ||
| The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. | Q46738154 | ||
| Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels | Q46835777 | ||
| Myocardial protection against reperfusion injury: the cGMP pathway. | Q51732054 | ||
| Protein kinase G Iα oxidation paradoxically underlies blood pressure lowering by the reductant hydrogen sulfide. | Q54318607 | ||
| Delayed phospholamban phosphorylation in post-conditioned heart favours Ca2+ normalization and contributes to protection. | Q54338197 | ||
| cGMP/PKG pathway mediates myocardial postconditioning protection in rat hearts by delaying normalization of intracellular acidosis during reperfusion. | Q54608833 | ||
| Urodilatin limits acute reperfusion injury in the isolated rat heart | Q73573586 | ||
| The production of hydrogen sulfide limits myocardial ischemia and reperfusion injury and contributes to the cardioprotective effects of preconditioning with endotoxin, but not ischemia in the rat | Q80027203 | ||
| Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts | Q83129828 | ||
| Protection through postconditioning or a mitochondria-targeted S-nitrosothiol is unaffected by cardiomyocyte-selective ablation of protein kinase G | Q86167719 | ||
| Hydrogen sulfide mediates the vasoactivity of garlic | Q24673752 | ||
| Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease | Q26823796 | ||
| The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning | Q26825733 | ||
| Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning | Q28080777 | ||
| Murine cystathionine gamma-lyase: complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression | Q28506768 | ||
| Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A | Q28574416 | ||
| Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R | Q28576521 | ||
| Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function | Q30480176 | ||
| Hydrogen sulfide is an endogenous stimulator of angiogenesis. | Q30492603 | ||
| Genetic and pharmacologic hydrogen sulfide therapy attenuates ischemia-induced heart failure in mice | Q30497008 | ||
| Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. | Q33606564 | ||
| H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway | Q33924111 | ||
| Inhaled nitric oxide improves outcomes after successful cardiopulmonary resuscitation in mice | Q34022784 | ||
| Hydrogen sulfide accounts for the peripheral vascular effects of zofenopril independently of ACE inhibition. | Q34402692 | ||
| Hydrogen sulfide cytoprotective signaling is endothelial nitric oxide synthase-nitric oxide dependent | Q34403540 | ||
| Cardioprotective PKG-independent NO signaling at reperfusion | Q34426209 | ||
| Phosphodiesterase-5 inhibitor, tadalafil, protects against myocardial ischemia/reperfusion through protein-kinase g-dependent generation of hydrogen sulfide | Q34503391 | ||
| cGMP-dependent protein kinase contributes to hydrogen sulfide-stimulated vasorelaxation. | Q34535138 | ||
| Cardioprotective effects of hydrogen sulfide | Q35115617 | ||
| Protein kinase G-regulated production of H2S governs oxygen sensing | Q35565640 | ||
| Cardioprotection by H2S engages a cGMP-dependent protein kinase G/phospholamban pathway. | Q35661834 | ||
| Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide. | Q35850118 | ||
| The polysulfide diallyl trisulfide protects the ischemic myocardium by preservation of endogenous hydrogen sulfide and increasing nitric oxide bioavailability | Q36042694 | ||
| Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling | Q36144664 | ||
| Vardenafil protects isolated rat hearts at reperfusion dependent on GC and PKG | Q36735813 | ||
| H₂S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase | Q36895184 | ||
| Hydrogen sulfide attenuates cardiac dysfunction after heart failure via induction of angiogenesis | Q37285009 | ||
| Hydrogen sulfide mediates cardioprotection through Nrf2 signaling | Q37328256 | ||
| Polysulfides link H2S to protein thiol oxidation. | Q37334548 | ||
| Enzymology of H2S biogenesis, decay and signaling | Q37543232 | ||
| Natriuretic peptides modulate ATP-sensitive K(+) channels in rat ventricular cardiomyocytes | Q37633999 | ||
| Hydrogen sulfide-mediated myocardial pre- and post-conditioning | Q37849578 | ||
| Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
| Evolutionary and comparative aspects of nitric oxide, carbon monoxide and hydrogen sulfide | Q38006568 | ||
| P433 | issue | 5 | |
| P921 | main subject | reperfusion injury | Q1413991 |
| P304 | page(s) | 510 | |
| P577 | publication date | 2015-08-30 | |
| P1433 | published in | Basic Research in Cardiology | Q2453360 |
| P1476 | title | Hydrogen sulfide and PKG in ischemia-reperfusion injury: sources, signaling, accelerators and brakes | |
| P478 | volume | 110 |
| Q38991916 | Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications |
| Q46500197 | Hydrogen sulfide: A novel mechanism for the vascular protection by resveratrol under oxidative stress in mouse aorta. |
| Q47914860 | International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors |
| Q55515112 | Low-Cytotoxicity Fluorescent Probes Based on Anthracene Derivatives for Hydrogen Sulfide Detection. |
| Q38643114 | Using hydrogen sulfide to design and develop drugs |
Search more.